Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 89.93 Delayed Data As of 4:00pm ET |  +2.41 / +2.75%Today’s Change | 18.47 Today|||52-Week Range 95.00 | +136.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -1.5M | -6.2M | -47.7M | -80.5M | |
| Depreciation | 1.8M | 682.0K | 437.0K | 431.0K | ||
| Total Other Cash Flow | 2.1M | 2.4M | 6.7M | 12.4M | ||
| Funds From Operations | 20.2M | -3.2M | -40.6M | -67.7M | ||
| Funds From/For Other Operating Expenses | 64.9M | 16.1M | 42.7M | 16.1M | ||
| Net Cash Flow - Operating Activities | -44.6M | -19.3M | -83.3M | -83.8M | ||
| Investing | Capital Expenditures | -272.0K | -340.0K | -344.0K | -679.0K | |
| Fixed Asset Disposal | 12.0K | 1.0K | 1.0K | 0.00 | ||
| Net Cash Flow Investing | -260.0K | -339.0K | -343.0K | -679.0K | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 265.0K | 19.5M | 57.7M | ||
| Long Term Debt Reduction | -45.0K | -45.0K | -45.0K | 0.00 | ||
| Net Proceeds Stock Sale | 39.0K | 62.1M | 109.2M | 234.8M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | 4.0K | 0.00 | 0.00 | ||
| Other Uses - Financing | 864.0K | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | -870.0K | 62.3M | 128.6M | 292.5M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -45.8M | 42.7M | 45.0M | 208.0M | ||
